Cargando…
Production and Clinical Evaluation of Norwalk GI.1 Virus Lot 001-09NV in Norovirus Vaccine Development
BACKGROUND: Human noroviruses (HuNoV) are the leading cause of gastroenteritis. No vaccine is currently available to prevent norovirus illness or infection. Safe, infectious challenge strains are needed to assess vaccine efficacy in the controlled human infection model (CHIM). METHODS: A stock of Hu...
Autores principales: | Mateo, Roberto, Lindesmith, Lisa C, Garg, Shaily J, Gottlieb, Keith, Lin, Karen, Said, Sara, Leon, Juan S, Sims, Amy C, Weber, David J, Baric, Ralph S, Tucker, Sean N, Taylor, David N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050988/ https://www.ncbi.nlm.nih.gov/pubmed/31628848 http://dx.doi.org/10.1093/infdis/jiz540 |
Ejemplares similares
-
Serum Immunoglobulin A Cross-Strain Blockade of Human Noroviruses
por: Lindesmith, Lisa C., et al.
Publicado: (2015) -
Norovirus Immunity and the Great Escape
por: Debbink, Kari, et al.
Publicado: (2012) -
Secretory pathway antagonism by calicivirus homologues of Norwalk virus nonstructural protein p22 is restricted to noroviruses
por: Crawford, Sue E, et al.
Publicado: (2012) -
NORWALK AND RELATED VIRUSES (CALICIVIRIDAE)
por: Estes, Mary K., et al.
Publicado: (1999) -
Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes
por: Verardi, Raffaello, et al.
Publicado: (2020)